Raphael Catane

Division of Oncology, Sheba Health Center, Israel

Professor & Chairman, Department of Oncology, Sheba Medical Center

Educated at the Hebrew-University Hadassah Medical Center in Jerusalem, Israel with Fellowships at the Roswell Park Cancer Institute of Buffalo, New York and at the National Cancer Institute, NIH of Bethesda MD.

My main interest in breast cancer is its genetics and the development of new treatments. The clinical Department offers training for exceptionally talented young physicians.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Oncology > Breast Diseases: Benign & Malignant (since 11 November 2005)

All recent recommendations

• 9.0
  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.
  Recommended by Raphael Catane with Jair Bar
  
• 6.0
  Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
  Recommended by Raphael Catane
  
• 6.0
  Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
  Recommended by Raphael Catane
  
• 3.0
  Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
  Recommended by Raphael Catane